PSA test

Mayo Clinic Health Manager

Get free personalized health guidance for you and your family.

Get Started

Free

E-Newsletter

Subscribe to receive the latest updates on health topics. About our newsletters

  • Housecall
  • Alzheimer's caregiving
  • Living with cancer

Definition

By Mayo Clinic staff

The PSA test is used primarily to screen for prostate cancer before symptoms appear. A PSA test measures the amount of prostate-specific antigen (PSA) in your blood. PSA is a protein produced in the prostate, a small gland about the size and shape of a walnut that sits below a man's bladder. Small amounts of PSA ordinarily circulate in the blood.

The prostate produces and releases a component of semen, the fluid that transports sperm during ejaculation. Some problems with the prostate, such as an enlarged prostate and prostate cancer, become more likely as men age.

Use of the PSA test is controversial. It's important to discuss with your doctor whether you should get a PSA test and what the results may mean.

References
  1. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine. 2008;149:185.
  2. Overview: Prostate cancer. How many men get prostate cancer? American Cancer Society. http://www.cancer.org/docroot/CRI/content/CRI_2_2_1X_How_many_men_get_prostate_cancer_36.asp?sitearea=. Accessed Feb. 16, 2009.
  3. The prostate-specific antigen (PSA) test: Questions and answers. National Cancer Institute. http://www.cancer.gov/cancertopics/factsheet/detection/PSA. Accessed Feb. 12, 2009.
  4. What You Need to Know About Prostate Cancer. Rockville, Md.: National Cancer Institute; 2008.
  5. Can prostate cancer be found early? American Cancer Society. http://www.cancer.org/docroot/cri/content/cri_2_4_3x_can_prostate_cancer_be_found_early_36.asp. Accessed Feb. 12, 2009.
  6. Lin K, et al. Benefits and harms of prostate-specific antigen screening for prostate cancer: An evidence update for the U.S. Preventive Services Task Force. Annals of Internal Medicine. 2008;149:192.
  7. Prostate cancer: Screening. Centers for Disease Control and Prevention. http://www.cdc.gov/cancer/prostate/basic_info/screening.htm. Accessed Feb. 15, 2009.
  8. Ferrini R, et al. Screening for prostate cancer in American men: American College of Preventive Medicine Practice Policy Statement. American College of Preventive Medicine. http://www.acpm.org/prostate.htm. Accessed Feb. 15, 2009.
  9. Early detection of prostate cancer. American Urological Association. http://www.auanet.org/content/guidelines-and-quality-care/policy-statements/e/early-detection-of-prostate-cancer.cfm. Accessed Feb. 16, 2009.
  10. Andriole GL, et al. Mortality results from a randomized prostate-cancer screening trial. New England Journal of Medicine. 2009;360:1310.
  11. Schroder FH, et al. Screening and prostate-cancer mortality in a randomized European study. New England Journal of Medicine. 2009;360:1320.
  12. Carroll P, et al. Prostate-specific antigen best practice statement: 2009 update. American Urological Association. http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines/main-reports/psa09.pdf. Accessed April 28, 2009.

MY00180

May 13, 2009

© 1998-2009 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Reliable tools for healthier lives," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

Print Share Reprints

Text Size: smaller largerlarger